Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Best consumed regularly for optimal results
Wegovy and Zepbound are FDA approved for weight loss, while Ozempic and Mounjaro are approved for Type 2 diabetes
Given its efficacy in controlling blood sugar and facilitating weight loss, tirzepatide could emerge as a preferred option for certain patients, especially for those where weight management is a priority
TrumpRx Expansion (January 2026): National rollout puts GLP-1 injectables like Wegovy and Zepbound within reach for employees at approximately $350/month, with prices predicted to drop to $250/month in the next two years for cash-pay consumers
Dietary habits
Human islets were maintained in culture for up to 48h in RPMI medium containing 10% fetal bovine serum (FBS), 1% penicillin/streptomycin and 5 mM glucose
US$ 23.14
US$ 28.37
US$ 28.81
US$ 23.75
